Furthermore, the current authors suggest that the nerve growth factor (NGF)-tropomyosin receptor kinase A (TrkA) axis signaling plays a role in promoting the development of this dose-limiting and threshold-driven Piezo2 channelopathy that may explain the sex difference in the epidemiology of DED. The gene discussed is PIEZO2; the disease is channelopathy.